Oncology PracticeOmitting postop radiotherapy doesn’t affect survival in older breast cancer patientsDecember 21, 2020Breast Cancer
Oncology PracticeMargetuximab approved for HER2-positive metastatic breast cancerDecember 18, 2020Breast CancerMetastatic Breast Cancer
Oncology PracticeMost common cancer diagnosis globally: Breast surpasses lungDecember 17, 2020Breast CancerLung Cancer
Oncology PracticeAn all-oral option for advanced HR+, HER2– breast cancer?December 17, 2020Breast CancerMetastatic Breast Cancer
Oncology PracticePembro benefits in mTNBC regardless of chemo typeDecember 16, 2020Breast CancerMetastatic Breast Cancer
Oncology PracticeFirst-in-class ADC has benefit across mTNBC subgroupsDecember 14, 2020Breast CancerMetastatic Breast Cancer
Oncology PracticeAdding atezolizumab to chemo doesn’t worsen QOL in early TNBCDecember 14, 2020Breast Cancer
Oncology PracticePregnancy after breast cancer is rockier but doesn’t increase recurrence riskDecember 11, 2020Breast Cancer
Oncology PracticeRxPONDER: Even more women may forgo chemo for breast cancerDecember 11, 2020Breast Cancer
Oncology PracticeBreast cancer survival disparities: Need to address obesityDecember 11, 2020Breast CancerDiversity in Medicine
Oncology PracticeDiabetes prevention diet may lower mortality risk in breast cancerDecember 10, 2020Breast Cancer
Oncology PracticemonarchE: Abemaciclib reigns on in high-risk breast cancerDecember 10, 2020Breast Cancer
Oncology PracticePENELOPE-B: Palbociclib disappoints in HR+, HER2– breast cancerDecember 10, 2020Breast Cancer
Oncology PracticeBreast surgery may be a gateway to addictive medication useDecember 9, 2020Breast Cancer
